GILD - GILEAD SCIENCES, INC.
147.83
-2.200 -1.488%
Share volume: 6,356,236
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$150.03
-2.20
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-12-2024 | 02-28-2025 | 05-07-2025 | 08-07-2025 | 11-07-2025 | 02-24-2026 | |
| Total revenue | 6.686 B | 6.954 B | 7.545 B | 7.569 B | 6.667 B | 7.082 B | 7.769 B | 7.925 B | |
| Cost of revenue | 1.552 B | 1.544 B | 1.574 B | 1.581 B | 1.540 B | 1.501 B | 1.569 B | 1.624 B | |
| Gross profit | 5.134 B | 5.410 B | 5.971 B | 5.988 B | 5.127 B | 5.581 B | 6.200 B | 6.301 B | |
| 5.38% | 10.37% | 0.28% | -14.38% | 8.86% | 11.09% | 1.63% | |||
| Operating expenses | 7.026 B | 2.766 B | 3.333 B | 3.536 B | 2.890 B | 2.917 B | 2.873 B | 3.917 B | |
| Selling general and admin | 1.375 B | 1.377 B | 1.433 B | 1.906 B | 1.258 B | 1.365 B | 1.357 B | 1.794 B | |
| Research and development | 5.651 B | 1.389 B | 1.900 B | 1.630 B | 1.632 B | 1.552 B | 1.516 B | 2.123 B | |
| Total expenses | 9.456 B | 2.766 B | 5.083 B | 3.536 B | 2.890 B | 3.107 B | 2.873 B | 4.317 B | |
| -70.75% | 83.77% | -30.43% | -18.27% | 7.51% | -7.53% | 50.26% | |||
| Operating income | -4.322 B | 2.644 B | 888.000 M | 2.452 B | 2.237 B | 2.474 B | 3.327 B | 1.984 B | |
| Ebit | -4.231 B | 2.289 B | 1.194 B | 2.416 B | 1.909 B | 2.682 B | 3.896 B | 2.333 B | |
| Pretax income | -4.486 B | 2.053 B | 956.000 M | 2.167 B | 1.649 B | 2.429 B | 3.641 B | 2.077 B | |
| -145.76% | -53.43% | 126.67% | -23.90% | 47.30% | 49.90% | -42.96% | |||
| Income tax | -315.000 M | 438.000 M | -297.000 M | 385.000 M | 334.000 M | 468.000 M | 589.000 M | -105.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.170 B | 1.614 B | 1.253 B | 1.783 B | 1.315 B | 1.960 B | 3.052 B | 2.183 B | |
| 138.71% | -22.37% | 42.30% | -26.25% | 49.05% | 55.71% | -28.47% |